AbCellera Biologics (ABCL) Exchange Rate Effect (2021 - 2026)
AbCellera Biologics (ABCL) posted Exchange Rate Effect of -$38000.0 for Q1 2026, down 113.1% on a QoQ basis from $290000.0 in Q4 2025, and down 106.44% year-over-year from $590000.0 in Q1 2025.
AbCellera Biologics (ABCL) Exchange Rate Effect (2021 - 2026) Analysis & Trends
AbCellera Biologics' Exchange Rate Effect history runs 6 years deep, the most recent figure standing at -$38000.0 for Q1 2026.
- Quarterly Exchange Rate Effect fell 106.44% year-over-year to -$38000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $469000.0 (up 137.64% YoY) and the FY2025 annual result came in at $1.1 million, up 141.92% from the prior year.
- Exchange Rate Effect was -$38000.0 for Q1 2026 at AbCellera Biologics, down from $290000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $1.1 million in Q4 2023 and bottomed at -$8.6 million in Q3 2022.
- A 5-year average of -$621647.1 and a median of -$43000.0 in 2024 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect tumbled 3841.01% — and 2025, when it surged 1869.77%.
- AbCellera Biologics' Exchange Rate Effect stood at $364000.0 in 2022, then jumped by 193.41% to $1.1 million in 2023, then sank by 302.25% to -$2.2 million in 2024, then soared by 113.43% to $290000.0 in 2025, then plunged by 113.1% to -$38000.0 in 2026.
- Business Quant data shows ABCL's Exchange Rate Effect at -$38000.0 in Q1 2026, $290000.0 in Q4 2025, and -$544000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | AbCellera Biologics | 1.72 Bn | 1.72 Bn | - | -38,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38,000.00 |
| Mar 31, 2026 | -38,000.00 |
| Dec 31, 2025 | 290,000.00 |
| Dec 31, 2025 | 290,000.00 |
| Sep 30, 2025 | -544,000.00 |
| Sep 30, 2025 | -544,000.00 |
| Jun 30, 2025 | 761,000.00 |
| Jun 30, 2025 | 761,000.00 |
| Mar 31, 2025 | 590,000.00 |
| Mar 31, 2025 | 590,000.00 |
| Dec 31, 2024 | -2.16 Mn |
| Dec 31, 2024 | -2.16 Mn |
| Sep 30, 2024 | 367,000.00 |
| Sep 30, 2024 | 367,000.00 |
| Jun 30, 2024 | -43,000.00 |
| Jun 30, 2024 | -43,000.00 |
| Mar 31, 2024 | -781,000.00 |
| Mar 31, 2024 | -781,000.00 |
| Dec 31, 2023 | 1.07 Mn |
| Dec 31, 2023 | 1.07 Mn |